baber/WOPTO huggingface dataset:
Patent EP-1131361-A1 (EP)
Inventor: BERARDI ALAIN
IPC: C08F4/70
Filed: 1999-10-21
Abstract: The present invention relates to a process for the polymerization and copolymerization of 1-olefins and to a catalyst to be used in said process wherein the catalyst comprises (1) a complex having formula (I) wherein M is Fe[II], Fe[III], Co[I], Co[II], Co[III], Mn[I], Mn[II], Mn[III], Mn[IV], Ru[II], Ru[III] or Ru[IV]; X represents an atom or group covalently or ionically bonded to the metal M; T is the oxidation state of the metal; b is the valency of the atom or group X; and R 1 to R 7 are each independently selected from hydrogen, halogen, hydrocarbyl, substituted hydrocarbyl, heterohydrocarbyl, substituted heterohydrocarbyl or SiR' 3 where each R' is independently selected from hydrogen, halogen, hydrocarbyl, substituted hydrocarbyl, heterohydrocarbyl, substituted heterohydrocarbyl; and when any two or more of R 1 to R 7 are hydrocarbyl, substituted hydrocarbyl, heterohydrocarbyl or substituted heterohydrocarbyl, said two or more can be linked to form one or more cyclic substituents; (2) an activator which is an alkylalumoxane; and (3) a support material, wherein the atomic ratio of aluminium in the alkylalumoxane (2) to transition metal M in (1) is from 6:1 to 25:1.
Patent EP-1044332-A1 (EP)
Inventor: KOERNER TILLMANN
IPC: F04C2/08
Filed: 1999-10-18
Abstract: Die Erfindung betrifft eine Baureihe für Zahnradmotoren für unterschiedliche Fördervolumina mit wenigstens zwei Zahnradmotoren (1, 100). Jeder Zahnradmotor weist wenigstens zwei miteinander kämmende Verdrängerelemente (45, 104, 105), ein erstes Verdrängerelement (4, 104) und ein zweites Verdrängerelement (5, 105), in Form von Zahnrädern auf. Die einzelnen Zahnradmotoren der Baureihe weisen a) im wesentlichen identische Abmessungen für den Achsabstand (a) zwischen den theoretischen Achsen bzw. den theoretischen Rotationsachsen der beiden Verdrängerelemente und b) eine im wesentlichen identische Verzahnungsbreite (zb1, zb2) in Form einer im wesentlichen identischen axialen Erstreckung der Verzahnungselemente auf. Die einzelnen Zahnradmotoren unterscheiden sich wenigstens hinsichtlich der Grösse des Kopfkreisdurchmessers (dk1, dk2, dk1b, dk2b) wenigstens eines der beiden Verdrängerelemente voneinander.
Patent EP-1126829-A1 (EP)
Inventor: ZUCCARELLI JEAN-MARC
IPC: A61K47/02
Filed: 1999-11-03
Abstract: The invention concerns coated particles based on granulated microcrystals of ibuprofen, its pharmaceutically acceptable isomers and salts, characterized in that they comprise a coating obtained in a fluidized bed apparatus with a hydroalcoholic dispersion consisting of a mixture comprising (A) 5 to 50% by weight of ethylcellulose relative to ibuprofen; (B) 10 to 60% by weight of hydroxypeopylmethylcellulose relative to the ethylcellulose; and (C) 1 to 40% by weight of silica with antistatic and permeabilizing properties relative to the ethylcellulose, the resulting coating, whereof at least one of the constituents can be used for granulating the ibuprofen microcrystals resulting in said particles, thereby masking the unpleasant taste of ibuprofen and significantly reducing its irritating effect on the throat after deglutition and substantially immediate release of ibuprofen when the particles are placed in an aqueous medium.
Patent EP-1229831-A1 (EP)
Inventor: AHN BYUNG-SUNG
IPC: A61B5/308
Filed: 1999-11-06
Abstract: L'invention se rapporte à un système d'électrocardiographie ayant une tête de mesure isolée électriquement à partir de laquelle des électrodes sont attachées à un patient de manière que la précision du test électrocardiographique puisse être accrue sans choc électrique. Le système de cette invention comporte: une tête de mesure conçue pour recevoir des signaux électrocardiographiques détectés par les électrodes de détection et pour générer des signaux de tension de différence à partir des signaux électrocardiographiques reçus, la tête de mesure isolée étant alimentée par une première alimentation électrique; un lien de transmission conçu pour transmettre les signaux de tension de différence; et un générateur de tension induite conçu pour recevoir les signaux de tension de différence via le lien de transmission et pour générer des signaux de tension induite, ladite tête de mesure étant électriquement isolée du générateur de tension induite qui est, lui, alimenté par une seconde alimentation électrique.
Patent EP-1115615-A1 (EP)
Inventor: ROTH MARTIN
IPC: E05B47/00
Filed: 1999-09-14
Abstract: L'invention concerne un mécanisme de retenue et de libération comportant un actionneur à mémoire de forme. L'invention vise à mettre au point un mécanisme de retenue et de libération muni d'un actionneur à mémoire de forme, qui permette d'obtenir une libération fiable, tout étant de structure simple et en ne nécessitant qu'un faible apport énergétique. A cet effet, il est prévu que l'extrémité de conducteur (7, 8) soit maintenue par une extrémité lâche d'un conducteur à mémoire de forme (9, 10), qui se contracte dans le sens de son axe longitudinal lorsque la température augmente et retire son extrémité lâche d'une ouverture (27, 28) formée par l'extrémité du conducteur (7, 8). L'invention s'utilise dans un mécanisme de retenue et de libération comportant un actionneur à mémoire de forme, qui libère, en température commandée, une extrémité de conducteur se trouvant sous contrainte de traction.
Patent EP-1062962-A1 (EP)
Inventor: OHKI HISATOMO
IPC: A61M15/00
Filed: 1999-12-27
Abstract: A diffusion chamber block 14 is provided in a block
mounting hole 13A of an inhalant port 13, and a granular
medicine diffusion chamber 17 is formed in the diffusion
chamber block 14. The granular medicine diffusion
chamber 17 is formed at a side of the inhalant port 13
with a granular medicine inflow opening 17A and at a side
of a capsule housing hole 9 with a granular medicine
outflow opening 17B. A diffusion chamber inflow passage
18 is provided to communicate an outflow air passageway
12 with the granular medicine inflow opening 17A, whereas
a diffusion chamber outflow passage is provided to
communicate the granular medicine outflow opening 17B
with the inhalant port 13. When inhaling granular
medicines in the capsule housing hole 9 via the inhalant
port 13 by way of breathing action, there results in
counter-flow vortex within the granular medicine
diffusion chamber 17. The counter-flow cortex acts to
finely break and atomize massive granular medicines, thus
promoting atomization of the granular medicines.
Patent EP-1140550-A1 (EP)
Inventor: BRAND WERNER
IPC: B60L5/22
Filed: 1999-11-26
Abstract: The aim of the invention is to significantly reduce the construction space required for the current collector head and at the same time reduce noise emission and wear on the wearing strip. To this end, the rocker (4) consists of at least two single-piece angle levers (10) which are oriented parallel to the contact wire and arranged perpendicular to each other and which form an angle (8, 9) and have lever arms (8, 9) of different lengths. Said rectangular levers are each arranged in such a way that they can pivot about a common, fixed centre of rotation, against the force of a tension spring (12) of slight rigidity which acts approximately vertically on the shorter lever (9). The longer lever arm (8) presses directly against the wear strip arrangement and moves the latter in an approximately vertical direction on a part of a circular path with a very large diameter as it rises and falls. A hydraulic rotation damper (13) is located between the angle levers (10) and is actively connected to the same.
Patent EP-1070008-A1 (EP)
Inventor: CECCHI SIRO VASCO
IPC: B64B1/32
Filed: 1999-12-14
Abstract: The aircraft comprises a relatively bulky body (1) containing lighter gas than the air, and carrying surfaces (3, 5) set to cause, in the forward movement, the lift needed to raise the aircraft.
Patent EP-1243123-A1 (EP)
Inventor: VALLINEN JUHA
IPC: H04M3/48
Filed: 1999-12-21
Abstract: La présente invention concerne un procédé pour effectuer un rappel d'abonné ayant laissé un message dans un système de télécommunication. Ce dernier système comprend au moins un commutateur de service mobile (MSC)  pour commuter les appels entre au moins deux abonnés (A, C) ou entre l'un desdits abonnés et un serveur de messages (VMS/SN). Ce serveur de messages est adapté pour conserver un enregistrement de plusieurs messages précédents s'adressant à un abonné appelé (A), lesquels messages sont enregistrés dans le serveur de messages à partir d'un abonné appelant correspondant (C). Ce procédé comprend les étapes consistant à effectuer (S6) un appel de rappel de la part de l'abonné appelé (A) vers l'abonné appelant (C) en fonction des informations enregistrées dans ledit serveur de messages, via au moins un desdits commutateurs de service mobile (MSC), puis à ce moment, de faire passer le système dans un état permettant audit abonné appelé (A) de se connecter de nouveau audit serveur de messages (VMS/SN) une fois le rappel terminé. En outre, l'invention traite aussi d'un dispositif de commande correspondant ainsi que d'un élément de réseau comprenant ce dernier.
Patent EP-1140888-A1 (EP)
Inventor: MAKINGS LEWIS
IPC: A61P43/00
Filed: 1999-12-10
Abstract: The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods. The optical probe of the invention is a compound having the generic structure Y-L-Q, wherein Y is selected from the group consisting of Q as herein defined, saturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl, unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkenyl, unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkynyl, substituted saturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkenyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkynyl, C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkyl, C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkenyl, substituted saturated C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkenyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl; L is selected from the group of (-OCR<SUP>2</SUP>H)<SUB>p</SUB>-, wherein for each p, all R<SUP>2 </SUP>are separately selected from the group consisting of a hydrogen atom, saturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl, unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkenyl, unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkynyl, substituted saturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkenyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkynyl, C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkyl, C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkenyl, substituted saturated C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkenyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and p is a positive integer no greater than twelve; and Q is a chemical moiety that gives rise to optical properties in its hydroxy or hydroxylate, phenol or phenoxide form that are different from the optical properties that arise from its ether form. Most preferably, p is one, R<SUP>2 </SUP>is hydrogen, and Q is the ether form of a phenoxide fluorophore.
Patent EP-1142305-A1 (EP)
Inventor: GEORGE JOHN BARRETT
IPC: H04N3/26
Filed: 1999-12-21
Abstract: Afin de mesurer précisément une faible polarisation de courant dans un circuit de polarisation de kinéscope automatique (AKB) sur plusieurs lignes vidéo qui suivent immédiatement un retour de trame, la focalisation dynamique est interrompue par désactivation d'un amplificateur de tension de focalisation dynamique. L'amplificateur tire sa puissance d'un transformateur à retour de faisceau. Afin d'éviter l'apparition d'une transitoire horizontale lorsqu'on réactive l'amplificateur de tension de focalisation dynamique après sa désactivation pendant un intervalle de suppression, l'amplificateur dynamique débite un courant pendant une suppression de trame qui est proche de courant moyen débité pendant un balayage vertical.
Patent EP-1054703-A1 (EP)
Title: Aiguille medicale creuse, courbe, superelastique
Inventor: MORRIS EDWARD J
IPC: A61B17/00
Filed: 1999-12-09
Abstract: L'invention concerne un ensemble aiguille (10), comprenant une aiguille d'injection (11) pourvue d'une canule d'aiguille (13) constituée d'un matériau superélastique tel que le nitinol. La canule d'aiguille est écrouie ou recuite à chaud, afin d'obtenir une courbure préformée (16) pouvant être redressée dans un passage (21) d'une canule extérieure (12) coaxiale, pour être introduite dans le corps d'un patient. Lors d'un déploiement à partir de la canule extérieure, la canule d'aiguille revient sensiblement à la configuration préformée, afin d'introduire des matériaux dans le chemin d'entrée de l'ensemble aiguille ou de les extraire dudit chemin, au niveau de zones latérales. L'ensemble aiguille comprend une pluralité de canules d'aiguille qui peuvent être agencées ou configurées de manière variable, afin d'atteindre un modèle d'injection désiré.
Patent EP-1131293-A1 (EP)
Title: 1-aminoethylquinoline derivatives for treating urinary incontinence
Inventor: PHILIPPO CHRISTOPHE
IPC: A61P13/10
Filed: 1999-11-10
Abstract: The invention concerns compounds of general formula (I) wherein: A represents a hydrogen atom, an azido, a halogen, a hydroxy, a thiol, an amino, a phenyl, a C1-C6 alkyl, C1-C6 alkylamino, di(C1-C6 alkyl)amino, hydroxylamine, C1-C6 alkyl hydroxylamine, N, O-C1-C6 dialkyl hydroxylamine, C1-C6 alkoxy or C1-C6 alkylsulphanyl group; B and D represent independently of each other a hydrogen atom, a phenyl, a C1-C6 alkyl, C2-C6 alkenyl, C1-C6 fluoroalkyl or C1-C6 perfluoroalkyl group, or together form an oxo; R1 represents a hydrogen atom, a halogen, a carbonyl, a cyano, a carboxamide, a C1-C6 alkyl, C2-C6 alkenyl, C3-C6 cycloalkyl, C1-C6 alkoxycarbonyl, C1-C6 hydroxyalkyl, C1-C6 alkoxy, C1-C6 alkoxy C1-C6 alkyl, C1-C6 fluoroalkyl, C1-C2 perfluoroalkyl or CF3(OH)CH group, or R1 and R2 together form, with the carbons whereto they are bound a phenyl; R5 and R6 represent, independently of each other, a hydrogen atom, a C1-C6 alkyl, C2-C6 alkenyl, C3-C6 cycloalkyl, C3-C6 cyloalkenyl, C1-C6 fluoroalkyl, C1-C2 perfluoroalkyl group or R5 and R6 together form a C2-C6 alkylene, C3-C6 alkenylene chain to produce with the nitrogen whereto they are bound a heterocycle, said heterocycle being optionally substituted by a C1-C4 alkyl group. The invention has therapeutic applications.
Patent FI-20216377-A1 (FI)
Title: Producing hydrocarbons from organic material of biological origin
Inventor: HOVI MERI
IPC: C10G3/00
Filed: 2021-12-30
Abstract: The present invention provides a process for producing hydrocarbons from a feedstock comprising organic material of biological origin, the process comprising a) providing a feedstock comprising organic material of biological origin, b) pre-treating the feedstock in one or more pre-treatment stages to obtain a purified feedstock, c) subjecting the purified feedstock to hydrotreatment to obtain a stream of hydrotreated feed, d) distilling the stream of hydrotreated feed to obtain at least two fractions, a first heavy bottom fraction, which is removed from the process, and a second middle fraction, which is collected for further treatment, e) subjecting the collected middle fraction to isomerization to obtain an isomerised stream of hydrocarbons.
Patent FI-20225065-A1 (FI)
Inventor: KÄRKI PASI
IPC: G01N1/02
Filed: 2022-01-27
Abstract: Esillä on uudenkaltainen suodosnäytteenotin (100a, 100b) suodosnäytteen keräämiseksi selluliuoksesta. Suodosnäytteenotin (100a, 100b) käsittää: vaipan (140a, 140b), männänvarren (110a, 110b), joka käsittää ensimmäisen pään (111a, 111b) ja toisen pään (112a, 112b), joka männänvarsi (110a, 110b) on järjestetty mainitun vaipan (140a, 140b) sisälle vaipan (140a, 140b) pituussuunnassa, ja rakosihdin (120a, 120b), joka on järjestetty männänvarteen (110a, 110b). Rakosihti (120a, 120b) käsittää lukuisia rakoja (123), jotka ulottuvat männänvarren (110a, 110b) pituussuunnan suuntaisesti.
Patent HK-1026934-A1 (HK)
Title: Magnetic particle damper apparatus
Inventor: AGNIHOTRI ASHOK K
IPC: B64C27/51
Filed: 2000-08-02
Abstract: A helicopter rotor assembly comprising a rotating yoke member, a blade member connected to the yoke member, the blade member being movable relative to the yoke member; and a magnetic particle damper (20). The magnetic particle damper (20), used to dampen motion between the yoke member and the blade (22,24), comprises two conductors (26,30), each attached to one of the movable parts by connecting rods (27,31), with the gap (32) between opposed facing surfaces being filled with dry magnetic particles, and magnets (28,34) mounted respectively on both conductors. - The magnets attached to the conductors produces a magnetic flux, confined to a magnetic flux path defined by the relative magnetically permeable and non-permeable regions of the conductors, which flows across the gap and through the magnetic particles. The magnetic field causes the magnetic particles along the flux path to adhere to one another and to the opposed facing surfaces of the conductors and to produce a force opposing the relative movement of the conductors to one another. <IMAGE>
Patent HK-1033409-A1 (HK)
Title: Loudspeaker drive unit having a resonant panel-form member
Inventor: AZIMA HENRY
IPC: H04R1/28
Filed: 2001-06-11
Abstract: A method of making an acoustic device in the form of a loudspeaker drive unit having a resonant panel-form member adapted to provide an acoustic output when excited with bending wave energy, comprising forming a resilient suspension for the panel-form member by molding and simultaneously fixing the resilient suspension to the panel-form member.
Patent HK-1033473-A1 (HK)
Title: Method for producing complex dna methylation fingerprints
Inventor: OLEK ALEXANDER
IPC: C12Q1/6886
Filed: 2001-06-15
Abstract: Method for characterizing, classifying and differentiating tissues and cell types, for predicting the behavior of tissues and groups of cells, and for identifying genes with changed expression. The method involves obtaining genomic DNA from a tissue sample, the genomic DNA subsequently being subjected to shearing, cleaved by means of a restriction endonuclease or not treated by either one of these methods. The base cytosine, but not 5-methylcytosine, from the thus-obtained genomic DNA is then converted into uracil by treatment with a bisulfite solution. Fractions of the thus-treated genomic DNA are then amplified using either very short or degenerated oligonucleotides or oligonuclcotides which are complementary to adaptor oligonucleotides that have been ligated to the ends of the cleaved DNA. The quantity of the remaining cytosines on the guanine-rich DNA strand and/or the quantity of guanines on the cytosine-rich DNA strand from the amplified fractions are then detected by hybridization or polymerase reaction, which quantities are such that the data generated thereby and automatically applied to a processing algorithm allow the drawing of conclusions concerning the phenotype of the sample material.
Patent HK-1040084-A1 (HK)
Title: Novel nucleosides and oligonucleotide analogues.
Inventor: KANEKO MASAKATSU
IPC: C07H19/167
Filed: 2002-02-26
Abstract: The object of the present invention is to provide novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer for starting amplification, and to novel nucleoside analogues which are intermediates for their production. ÄSolutionÜ   A compound of the formula (1): <CHEM> Äwherein R<1> and R<2> are the same or different and represent a hydrogen atom, a hydroxyl protecting group, a phosphoric acid group, or -P(R<3>)R<4> Äwherein R<3> and R<4> are the same or different and represent a hydroxyl group, an amino group, an alkoxy group having from 1 to 4 carbon atoms, a cyanoalkoxy group having from 1 to 5 carbon atoms or an amino group substituted by an alkyl group having from 1 to 4 carbon atomsÜ; A represents an alkylene group having from 1 to 4 carbon atoms; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group or a substituted purin-9-yl group or a substituted 2-oxo-pyrimidin-1-yl group having a substituent selected from the following  alpha groupÜ;  or the salt thereof; ( alpha  group> a hydroxyl group which may be protected, an alkoxy group having from 1 to 4 carbon atoms, a mercapto group which may be protected, an alkylthio group having from 1 to 4 carbon atoms, an alkoxy group having from 1 to 4 carbon atoms, an amino group which may be protected, a mono- or di-alkylamino group which may be substituted by an alkyl group having from 1 to 4 carbon atoms, an alkyl group having from 1 to 4 carbon atoms and a halogen atom. A compound of the formula (I), and the pharmacologically acceptable salts or derivatives thereof.
Patent HK-1049788-A1 (HK)
Title: Novel composition based on a thiazolidinedione andmetformin and use.
Inventor: LEWIS KAREN
IPC: A61K31/425
Filed: 2003-01-29
Abstract: A pharmaceutical composition, comprising a thiazolidinedione, such as Compound (I), metformin hydrochloride and a pharmaceutically acceptable carrier, wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier in the pharmaceutical composition and the use of such a composition in medicine.
Patent HK-1049367-A1 (HK)
Title: Integrated aqua-ammonia chiller/heater
Inventor: PAUL SARKISIAN
IPC: F25B33/00
Filed: 2003-02-25
Abstract: An aqua-ammonia chiller/heater apparatus is modified to provide a condenser and absorber refrigerant by-pass during a heater mode.
Patent HK-1050203-A1 (HK)
Title: Novel fusidic acid derivatives.
Inventor: DUVOLD TORE
IPC: C07J9/00
Filed: 2003-04-04
Abstract: Novel 17,20-dihydrofusidic acid derivatives are used in pharmaceutical compositions for the treatment of infections, in particular in topical compositions for the treatment of skin or eye infections.
Patent HK-1056154-A1 (HK)
Title: A collapsible container with a cooling agent.
Inventor: CHAN CHIK SUM
IPC: F25D3/08
Filed: 2003-09-19
Abstract: A collapsible container is disclosed as having a number of walls which are movable relative to one another between a collapsed configuration in which at least a major surface of at least two of the walls are in contact with each other, and an expanded configuration in which the walls define a cavity adapted to receive an article, e.g. cans or bottles of soft drinks and beers, and the walls contain a casing containing saline water.
Patent HK-1055732-A1 (HK)
Title: A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
Inventor: YOO MOO-HI
IPC: C07D239/00
Filed: 2003-11-06
Abstract: A method for preparing pyrazolopyrimidinone derivatives and their pharmaceutically acceptable salts having efficacy on the treatment of impotence, one of male sexual dysfunctions. The method comprises the steps of: a) chlorosulfonating a pyrazolamide compound to obtain a chlorosulfonated compound; b) reacting the chlorosulfonated compound of step (a) with a primary amine to obtain a sulfonamide compound and c) performing an intramolecular cyclization of the sulfonamide compound of step (b) to produce the compound of formula below 1, wherein the steps b) and c) are performed in situ in alcohol by adding a base to the reaction mixture without workup after the step b) is completed.